May 18 is HIV Vaccine Awareness Day (HVAD). As the COVID-19 pandemic has center stage this year, it is important to reflect upon the groundbreaking science in HIV vaccine R&D that has laid the foundations for COVID-19 vaccine research and development (R&D) and beyond. This HVAD, we celebrate the contributions that HIV vaccine R&D offers humanity, as we endeavor to overcome COVID-19 as a united and global community.
Access our toolkit to learn more and join IAVI and our partners in the call to keep our #EyesOnTheTarget of an HIV vaccine.
We are not on track to meet the Sustainable Development Goals’ target of ending HIV by 2030, with 1.7 million new HIV infections annually. Tweet this.
Modelling from UNAIDS and the World Health Organization (WHO) warns of 500,000 extra deaths from AIDS-related illnesses in 2020-2021 in sub-Saharan Africa due to service disruption. Tweet this.
Governments and funding bodies must invest wisely in innovations and solutions that benefit global health more broadly so that we are better prepared to confront both new and existing threats. Tweet this.